Considering the average of results from colon and lung cancers the significantly altered mRNAs associated with the presence of c-Myc that were shared, and thus likely redundant, with other two oncogenes was 44%, while mutant p53 and mutant KRAS had 55.5 and 66% likely redundant genes, respectively (Fig. 6E). The gene discussed is TP53; the disease is lung cancer.